As serum Ig levels in people with CIS did not correlate with levels of anti-EBV antibodies, there appears to be an expansion of IgG3-secreting cells with unknown antigen specificity or clonality which should be investigated. The gene discussed is IGHG3; the disease is in situ carcinoma.